Breaking

Syuhada Zulkifli

Boston Scientific Plans Restructuring $800M Charges Expected
Aid Ops

Boston Scientific Plans Restructuring $800M Charges Expected

Boston Scientific restructuring plan will incur up to $800 M in pre‑tax charges as the company shifts production and cuts jobs to…

Syuhada Zulkifli · 29/07/2026
User Account Blocked by Administrators
Crisis Cams

User Account Blocked by Administrators

Prevent drug diversion with multidisciplinary auditing and procurement checks beyond diversion surveillance software effectively.

Syuhada Zulkifli · 28/07/2026
User Account Blocked by Moderators
Aid Ops

User Account Blocked by Moderators

Sacituzumab govitecan is a new first-line treatment option for breast cancer patients with metastatic triple-negative breast cancer.

Syuhada Zulkifli · 25/07/2026
User Blocked from Accessing System
Live Outbreaks

User Blocked from Accessing System

Cancer patients often blur lines between cancer care and everyday medical management, requiring adaptability from oncologists and primary care doctors in cancer

Syuhada Zulkifli · 23/07/2026
Users Blocked From Accessing Website
Field Reports

Users Blocked From Accessing Website

Learn about the nonnegotiable bispecific dose protocols for safe administration in community oncology practices, as outlined by pharmacy leaders and experts.

Syuhada Zulkifli · 18/07/2026
Site Error Blocks Many Users Without Warning
Crisis Cams

Site Error Blocks Many Users Without Warning

A new study shows voice biomarkers on smartphones can detect worsening asthma or COPD flare-ups early, potentially reducing emergency hospital visits.

Syuhada Zulkifli · 17/07/2026
User Receives Unexpected Block Notification
Crisis Cams

User Receives Unexpected Block Notification

Remote monitoring myasthenia study shows daily app tracking uncovers symptom swings missed in clinic visits, offering new insights for patient care.

Syuhada Zulkifli · 16/07/2026
User Blocked After Policy Violation
Field Reports

User Blocked After Policy Violation

The veligrotug trial reveals a 2.9 mm reduction in proptosis for thyroid eye disease patients, offering a new FDA‑approved option beyond teprotumumab.

Syuhada Zulkifli · 14/07/2026
Users Report Unexpected Account Blocks Across Platforms
Health Streams

Users Report Unexpected Account Blocks Across Platforms

Users report unexpected account blocks across platforms, prompting concerns about security and access; discover why these blocks happen and how to resolve…

Syuhada Zulkifli · 14/07/2026
User Account Blocked by Social Media Platform
Crisis Cams

User Account Blocked by Social Media Platform

Musculoskeletal toxicities, including myalgias and arthralgias, impact up to 40% of patients on BTK inhibitors with muscle and joint pain.

Syuhada Zulkifli · 12/07/2026